|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lau WY and Lai EC: Hepatocellular
carcinoma: Current management and recent advances. Hepatobiliary
Pancreat Dis Int. 7:237–257. 2008.PubMed/NCBI
|
|
3
|
Zhou YM, Cao L, Li B, Zhang RX, Sui CJ,
Yin ZF and Yang JM: Clinicopathological significance of ZEB1
protein in patients with hepatocellular carcinoma. Ann Sung Oncol.
19:1700–1706. 2012. View Article : Google Scholar
|
|
4
|
Hubert C, Sempoux C, Rahier J, Horsmans Y,
Geubel A, Van Beers BE, Annet L, Zech F, Leonard D and Gigot JF:
Prognostic risk factors of survival after resection of
hepatocellular carcinoma. Hepatogastroenterology. 54:1791–1797.
2007.PubMed/NCBI
|
|
5
|
Sherman M: Recurrence of hepatocellular
carcinoma. N Engl J Med. 359:2045–2047. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang D, Cao L, Li Y, Lu H, Yang X and Xue
P: Expression of glioma-associated oncogene 2 (Gli2) is correlated
with poor prognosis in patients with hepatocellular carcinoma
undergoing hepatectomy. World J Surg Oncol. 29:252013. View Article : Google Scholar
|
|
7
|
Beachy PA, Karhadkar SS and Berman DM:
Tissue repair and stem cell renewal in carcinogenesis. Nature.
432:324–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wicking C, Smyth I and Bale A: The
hedgehog signaling pathway in tumorigenesis and development.
Oncogene. 18:7844–7851. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Berman DM, Karhadkar SS, Maitra A, De
Montes Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y,
Eshleman JR, Watkins DN and Beachy PA: Widespread requirement for
Hedgehog ligand stimulation in growth of digestive tract tumours.
Nature. 425:846–851. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ji J, Kump E, Wernli M and Erb P: Gene
silencing of transcription factor Gli2 inhibits basal cell
carcinomalike tumor growth in vivo. Int J Cancer. 122:50–56. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kubo M, Nakamura M, Tasaki A, Yamanaka N,
Nakashima H, Nomura M, Kuroki S and Katano M: Hedgehog signaling
pathway is a new therapeutic target for patients with breast
cancer. Cancer Res. 64:6071–6074. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thayer SP, di Magliano MP, Heiser PW,
Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del
Castillo C, Yajnik V, et al: Hedgehog is an early and late mediator
of pancreatic cancer tumorigenesis. Nature. 425:851–856. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thiyagarajan S, Bhatia N, Reagan-Shaw S,
Cozma D, Thomas-Tikhonenko A, Ahmad N and Spiegelman VS: Role of
GLI2 transcription factor in growth and tumorigenicity of prostate
cells. Cancer Res. 67:10642–10646. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Velcheti V and Govindan R: Hedgehog
signaling pathway and lung cancer. J Thorac Oncol. 2:7–10. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Von Hoff DD, LoRusso PM, Rudin CM, Reddy
JC, Yauch RL, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, et
al: Inhibition of the hedgehog pathway in advanced basal-cell
carcinoma. N Engl J Med. 361:1164–1172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gupta S, Takebe N and Lorusso P: Targeting
the hedgehog pathway in cancer. Ther Adv Med Oncol. 2:237–250.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Katano M: Hedgehog signaling pathway as a
therapeutic target in breast cancer. Cancer Lett. 227:99–104. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Karlstrom RO, Tyurina OV, Kawakami A,
Nishioka N, Talbot WS, Sasaki H and Schier AF: Genetic analysis of
zebrafish gli1 and gli2 reveals divergent requirements for gli
genes in vertebrate development. Development. 130:1549–1564. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Katoh Y and Katoh M: Hedgehog signaling,
epithelial-to-mesenchymal transition and miRNA (review). Int J Mol
Med. 22:271–275. 2008.PubMed/NCBI
|
|
20
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang ZS, Shen Y, Li X, Zhou CZ, Wen YG,
Jin YB and Li JK: Significance and prognostic value of Gli-1 and
Snail/E-cadherin expression in progressive gastric cancer. Tumour
Biol. 35:1357–1363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Odze RD and Goldblum JR: Surgical
pathology of the GI tract, Liver, Biliary Tract and Pancreas (2nd).
Saunders. Philadelphia: 13032009.
|
|
25
|
Hashiguchi M, Ueno S, Sakoda M, Iino S,
Hiwatashi K, Minami K, Ando K, Mataki Y, Maemura K, Shinchi H, et
al: Clinical implication of ZEB-1 and E-cadherin expression in
hepatocellular carcinoma (HCC). BMC Cancer. 13:5722013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dessaud E, McMahon AP and Briscoe J:
Pattern formation in the vertebrate neural tube: A sonic hedgehog
morphogen-regulated transcriptional network. Development.
135:2489–2503. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang ZC, Gao J, Zi SM, Yang M, Du P and
Cui L: Aberrant expression of sonic hedgehog pathway in colon
cancer and melanosis coli. J Dig Dis. 14:417–424. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kump E, Ji J, Wernli M, Häusermann P and
Erb P: Gli2 upregulates cFlip and renders basal cell carcinoma
cells resistant to death ligand-mediated apoptosis. Oncogene.
27:3856–3864. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eichberger T, Sander V, Schnidar H, Regl
G, Kasper M, Schmid C, Plamberger S, Kaser A, Aberger F and
Frischauf AM: Overlapping and distinct transcriptional regulator
properties of the GLI1 and GLI2 oncogenes. Genomics. 87:616–632.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Im S, Choi HJ, Yoo C, Jung JH, Jeon YW,
Suh YJ and Kang CS: Hedgehog related protein expression in breast
cancer: Gli-2 is associated with poor overall survival. Korean J
Pathol. 47:116–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karayiannakis AJ, Syrigos KN, Chatzigianni
E, Papanikolaou S, Alexiou D, Kalahanis N, Rosenberg T and
Bastounis E: Aberrant E-cadherin expression associated with loss of
differentiation and advanced stage in human pancreatic cancer.
Anticancer Res. 18:4177–4180. 1998.PubMed/NCBI
|
|
32
|
Winter JM, Ting AH, Vilardell F, Gallmeier
E, Baylin SB, Hruban RH, Kern SE and Iacobuzio-Donahue CA: Absence
of E-cadherin expression distinguishes noncohesive from cohesive
pancreatic cancer. Clin Cancer Res. 14:412–418. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Joo YE, Rew JS, Park CS and Kim SJ:
Expression of E-cadherin, alpha- and beta-catenins in patients with
pancreatic adenocarcinoma. Pancreatology. 2:129–137. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Castanon I and Baylies MK: A Twist in
fate: Evolutionary comparison of Twist structure and function.
Gene. 287:11–22. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kyo S, Sakaguchi J, Ohno S, Mizumoto Y,
Maida Y, Hashimoto M, Nakamura M, Takakura M, Nakajima M, Masutomi
K and Inoue M: High Twist expression is involved in infiltrative
endometrial cancer and affects patient survival. Hum Pathol.
37:431–438. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee TK, Poon RT, Yuen AP, Ling MT, Kwok
WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL and Fan ST: Twist
overexpression correlates with hepatocellular carcinoma metastasis
through induction of epithelial-mesenchymal transition. Clin Cancer
Res. 12:5369–5376. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ran Hong and Sung-Chul Lim: Overexpression
of Twist in colorectal adenocarcinoma. Basic and Applied Pathology.
2:15–20. 2009. View Article : Google Scholar
|
|
42
|
Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C,
Zhang X, Chua CW, Chan KW, Chan FL, Glackin C, et al: Up-regulation
of Twist in prostate cancer and its implication as a therapeutic
target. Cancer Res. 65:5153–5162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rosivatz E, Becker I, Specht K, Fricke E,
Luber B, Busch R, Höfler H and Becker KF: Differential expression
of the epithelial-mesenchymal transition regulators snail, SIP1,
and twist in gastric cancer. Am J Pathol. 161:1881–1891. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rosivatz E, Becker I, Bamba M, Schott C,
Diebold J, Mayr D, Höfler H and Becker KF: Neoexpression of
N-cadherin in E-cadherin positive colon cancers. Int J Cancer.
111:711–719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fackler MJ, McVeigh M, Evron E, Garrett E,
Mehrotra J, Polyak K, Sukumar S and Argani P: DNA methylation of
RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and
invasive lobular breast carcinoma. Int J Cancer. 107:970–975. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mehrotra J, Vali M, McVeigh M, Kominsky
SL, Fackler MJ, Lahti-Domenici J, Polyak K and Sacchi N: Very high
frequency of hypermethylated genes in breast cancer metastasis to
the bone, brain and lung. Clin Cancer Res. 10:3104–3109. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tamura G, Yin J, Wang S, Fleisher AS, Zou
T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, et al:
E-Cadherin gene promoter hypermethylation in rimary human gastric
carcinomas. J Natl Cancer Inst. 92:569–573. 2000. View Article : Google Scholar : PubMed/NCBI
|
